Alliance for Public Health’s Post

🌍 We're excited to announce the commencement of the 4th Brandenburg Forum on Drugs and Development Policies in #Geneva, co-hosted by #Switzerland, #Germany, #Norway, the #Netherlands, the Transnational Institute (TNI), and the International Drug Policy Consortium (IDPC). At this year's #BBFGeneva, we’re focusing on the critical need for transformative change in drug policy. Why do we need transformative change in #drugpolicy? We continue to witness: 🌱 Drug-related #deforestation, pollution, and the massive carbon footprint of drug value chains. 📈 Record-high levels of illicit drug crop cultivation and #trafficking. ⚖️ Drug-related criminal activities and violence undermining democratic institutions. 🚨 Ongoing drug-related #humanrights abuses and #publichealth crises. What do we need to do better together? The latest United Nations Human Rights report shows that policy design can either promote or hinder human rights. We need a development and human rights-oriented approach to drug policy. We believe that to effectively achieve this and to respond to an ever more complex and diversified global drug situation, it is crucial that we strengthen #InternationalDialogue, #multilateralism, UN inter-agency cooperation, system-wide coherence on drug-related issues, and that we protect the space for civil society involvement! Explore our story below on how human rights are shaping the future of drug policy. Der Sucht- und Drogenbeauftragte der Bundesregierung Federal Ministry for Economic Cooperation and Development (BMZ) Permanent Mission of the Kingdom of the Netherlands to the United Nations Permanent Mission of Norway in Geneva Rijksoverheid Drugs and Development Hub

Next week, Dec 4, we are starting to launch policy papers covering many dimensions of US domestic and supply side policies toward fentanyl & the spread of synthetic opioids Come hear insights from 9am-1:30pm ET https://lnkd.in/eyhKUZYx After introductions by Brookings VP Suzanne Maloney, the event will kick off w fireside chat former mayor of NYC Bill de Blasio about the harm reduction & other drug policies he pioneered in NYC. I am enormously excited about this convo. Dont miss it! Then 1st panel will feature NPR's Brian Mann speaking w Peter Reuter, Beau Kilmer, & Philomena Kebec about changes in US drug markets, vulnerable communities, such as Native Americans communities, & domestic law enforcement. It will also explore why overdose deaths have declined in the US & how that has happened highly unequally. The 2nd panel will feature Washington Post's Charles Lane speaking with Regina LaBelle, Harold Pollack, & Keith Humphreys about harm reduction, treatment, & decriminalization in US & Canada. The concluding panel will feature New York Times' Azam Ahmed speaking with me, Daniel Mejia, and Jon Caulkins about fentanyl supply from Mexico, China, & India; fentanyl spread in Latin America; & overall strategies toward supply-driven drug markets, incl prescribed safe supply. I am sure that President Elect Trump's threats of fentanyl-linked tariffs on China, Canada, & Mexico & unilateral action into Mexico will come up! Being just back from2 weeks in Mexico & China & a week in Canada in October looking at fentanyl supply and bilateral and multilateral coop, I will have thoughts. Dont miss the event, come to Brookings, listen online & register here: https://lnkd.in/eyhKUZYx

📢 May 7th is International Harm Reduction Day! 👉 #HarmReduction refers to policies, programs and practices that aim to minimize the negative health, social and legal impacts associated with drug use, drug policies and drug laws. 🏛️ Today is an opportunity to promote evidence-based drug policies based on #PublicHealth and #HumanRights. 📃 The #FutureDrugPolicyEU24 Manifesto outlines a vision for a pragmatic, innovative, and human rights-centered drug policy ahead of the European elections. 📝 To learn more about the initiative and priorities for the future of European and EU drug policy, join the webinar hosted by UNITE, Correlation - European Harm Reduction Network, International Drug Policy Consortium and NEWNet. Register at: https://lnkd.in/dtwvqbxT #SupportDontPunish

The drug supply in Scotland is changing. What is actually happening? How can we develop an adequate response in terms of service provision? How can we ‘get ahead of the curve’? Join us at our upcoming Trends in Drug Use and Harms in Scotland event.

#China is taking center stage in clinical trials. #Collaborations with other countries especially for rare diseases offer substantial #clinical & #drug development opportunities for cross border trade in #healthcare services. #ClinicalTrials #RareDiseases https://ow.ly/UQPC50UknOc

Today, the Global Commission on Drug Policy met with WHO Director-General Dr. Tedros to discuss the health implications of drug policies. Commissioners Michel Kazatchkine and Ruth Dreifuss emphasized key issues including: - Access to essential medicines - Harm reduction efforts - Drug policy reform The Global Commission continues to work closely with WHO to address these pressing challenges, driving progress towards a more just and health-centered approach to drug policy. #DrugPolicyReform #PublicHealth #HumanRights #GlobalHealth

NDRI WEBINAR: Drug checking around Australia: A snapshot of services, recent findings, and insights for the festival season Presenters: Stephanie Tzanetis (Pill Testing Australia) Cameron Francis (The Loop Australia, QLD) Dr Robert Page (The Loop Australia, NSW) Ed Broadbent (Prompt Response Network, National Centre for Research on Emerging Drugs) ­­Facilitated by Dr Jodie Grigg (National Drug Research Institute, Curtin University) In an evolving illicit drug risk environment, drug checking is increasingly recognised as a vital harm reduction tool for surveillance and informed decision-making. As we enter another Australian festival season, the risks posed by high-potency substances and novel synthetic substances, such as nitazines and cathinones, raise particular concerns. In this webinar, we’ll bring together a variety of experts from drug checking services across the country to explore the current landscape of drug checking and alert systems in Australia. Featuring four short presentations, we’ll cover how these services operate, their role in national surveillance and alert networks, trends in the illicit drug market, and key insights for the summer festival season! https://lnkd.in/gkHcaRr5

It was a great pleasure and an honor to be invited to speak alongside Helen Clark, Judy Chang and Ajeng Larasati on an all-female panel moderated by Kiti Kajana Phillips, MPH at the UNITE Global Parlamentarian Summit in Berlin yesterday. Every statement underlined the need to stronger align drug policies with International Human Rights committments - be it the promotion of life-saving harm reduction approaches, a meaningful involvement of people who use drugs or cultivate drug crops for sheer subsistance or criminal justice reforms in line with human dignity and non-discrimination. An important tool to guide the drafting and implementation of laws as well as for advocating for human rights- and development-centered drug policy reform are the International Guidelines on Human Rights and Drug Policy, available here: https://lnkd.in/dhMCm4W5 They have been translated in Arabic, French, Spanish, Russian and Portuguese and are guiding reform processes in favour of public health, sustainable development and basic human rights in drug policy approaches around the globe since their launch in 2019. A crucial instrument for the Parliamentarians organized in the global #UNITE Network to bring about fundamental change and promote global health and wellbeing without leaving anyone behind.

The Cuban drug that could come to America Relief for Americans with foot wounds caused by diabetes might come from an unlikely place: Cuba. A U.S. biotech company received Food and Drug Administration approval recently to run a clinical trial in America for Heberprot-P, a drug developed in Cuba nearly two decades ago that helps heal diabetes foot ulcers that could otherwise lead to amputation. Why it matters: About 1 in 3 people with diabetes develop a foot ulcer during their lives, according to an article last year in JAMA. In the U.S., 1.6 million people are affected. About half of diabetic foot ulcers become infected, and 1 in 5 of those lead to amputation. “There’s really nothing in America to treat these diabetic foot ulcers,” said Lee Weingart, a former Ohio county commissioner and current lobbyist who co-founded Discovery Therapeutics Caribe, which will run the clinical trial for the Cuban drug. Heberprot-P reduced amputations by 72 percent in foreign studies, he told an audience at a recent event promoting the island’s biotech at the Cuban embassy in Washington. The drug is available in more than two dozen other countries, but the decades-old U.S. sanctions on Cuba have hindered its path to America. See more at: https://lnkd.in/eermMw87

Tomorrow marks the start of the European elections, a crucial event for all EU Member States as they will determine the region’s outlook for the next 5 years and beyond. The 720 elected Members of the European Parliament will play a key role in shaping EU laws on sustainability, pharmaceuticals, and more.   This new parliament will continue vital discussions on the Pharmaceutical Legislation with the Member States and Commission. Key priorities include post-COVID-19 economic recovery, tackling the energy & inflation crisis, enhancing global competitiveness, and improving the health and wellbeing of EU citizens, with a strong focus on mental health over the next five years.   At Teva Pharmaceuticals we believe the further integration of a European dimension in the health and pharmaceutical sector is crucial, in order to strengthen regional abilities and resilience. Without a unified approach to health, Europe risks losing the valuable lessons learned from the pandemic. For more information and to read our recent study “the Critical Medicines Health Check” visit: https://bit.ly/49Yv8Yr   If you’re eligible don’t forget to vote, your vote counts! #EUelections #PharmaLegislation #AccesstoMedicines #UseYourVote